An emergency use listing would make the vaccine available in more than 190 countries, including multiple developing countries. If authorized, it would also allow J&J to supply the COVAX program – a global distribution and procurement agency that is helping manage COVID-19 vaccines for 190 participating countries.
In December, J&J came to an agreement with Gavi, the Vaccine Alliance, that is backing the COVAX program. If authorized, J&J expects to provide up to 500 million doses to COVAX through next year, the company said. “Our filing with the World Health Organization marks another important step in our effort to combat COVID-19 and also in our unwavering commitment to equitable access,” Dr. Paul Stoffels, Johnson & Johnson’s vice chair of the executive committee and chief scientific officer, said in a news release."If we are to end the global pandemic, life-saving innovations like vaccines must be within reach for all countries.
The COVID-19 vaccine’s efficacy against moderate and severe disease ranged from one country to another:It was 66% effective globally. This was measured starting one month after the shot. The vaccine is 85% effective overall at preventing hospitalization and 100% at preventing death in all regions where it was tested.
I wonder why the FDA here doesn't automatically grant EUA for vaccines that the WHO grants, why should it still go through the laborious process here?
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.